Investment Summary

Telegraph Hill Partners Invests In Nimble Therapeutics

On April 30, 2019, venture capital firm Telegraph Hill Partners invested in life science company Nimble Therapeutics

Investment Highlights
  • This is Telegraph Hill Partners’ 11th transaction in the Life Science sector.
  • This is Telegraph Hill Partners’ 27th transaction in the United States.
  • This is Telegraph Hill Partners’ 2nd transaction in Wisconsin.

Investment Summary
Date 2019-04-30
Target Nimble Therapeutics
Sector Life Science
Investor(s) Telegraph Hill Partners
Deal Type Venture

Target

Nimble Therapeutics

Madison, Wisconsin, United States
Nimble Therapeutics is a provider of massively parallel chemical synthesis to drug discovery. Nimble’s proprietary technology enables the synthesis and screening of millions of peptides, including scaffolded natural and modified macrocyclic peptidomimetics. Nimble Therapeutics was founded in 2019 and is based in Madison, Wisconsin.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Telegraph Hill Partners

San Francisco, California, United States

Investor Investor Investor Investor Investor

Category Venture Capital Firm
Founded 2001
Size Middle-Market
Type Sector Focused
DESCRIPTION

Telegraph Hill Partners is a specialist private equity firm focused on investing in later-stage life science, medical device, and healthcare companies. Prospective companies should be at or near profitability and demonstrate success. Other areas of interest within the healthcare sector include life science technologies, chemistry/reagent suppliers, and information management. Telegraph Hill Partners was formed in 2001 and is based in San Francisco, California.

DEAL STATS #
Overall 30 of 33
Sector (Life Science) 11 of 12
Type (Venture) 18 of 20
State (Wisconsin) 2 of 2
Country (United States) 27 of 30
Year (2019) 3 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-03-29 ObservSMART

West Chester, Pennsylvania, United States

ObservSMART provides pioneering products that solve the problems associated with high-reliability patient monitoring for high-risk patient populations. ObservSMART is based in West Chester, Pennsylvania.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-08-21 Emerging Therapy Solutions

Bloomington, Minnesota, United States

Emerging Therapy Solutions provides analytical software tools and outsourced services to insurance providers and other payers to manage expensive cell and gene therapies. Emerging Therapy Solutions was founded in 2018 and is based in Bloomington, Minnesota.

Buy -
Mergr

Product

Company

Legal